{ }
Teva Pharmaceutical Industries Limited reported third-quarter sales of USD 4,332 million, up from USD 3,850 million a year ago, but faced a net loss of USD 437 million compared to a net income of USD 69 million last year. For the nine months, sales increased to USD 12,315 million from USD 11,389 million, while the net loss widened to USD 1,422 million from USD 1,022 million. Basic and diluted loss per share from continuing operations were both USD 1.26, compared to USD 0.91 a year ago.
Toyota reported a 20% drop in operating profit to 1.16 trillion yen in Q3 2024, marking its first decline in two years due to production challenges and market issues in Japan and the U.S. The company faces intensified competition from Chinese brands, impacting its margins and market share.In response, Toyota plans to reduce incentives and improve production, with a revised annual forecast of 10.85 million vehicles. Despite these challenges, it maintained its full-year profit outlook at 4.3 trillion yen, which positively influenced its stock performance.
Swiggy's IPO saw a 7% subscription on its first day, with retail investors leading at 32%. The company reported a narrowed loss of Rs 611 crore for Q2 2024, compared to Rs 564 crore the previous year. Shares will be listed on November 13, following an allotment on November 11.
A South Korean celebrity chef, often compared to Gordon Ramsay, has become one of the world's richest chefs following a 36% surge in his restaurant franchise's trading debut, valuing his stake at approximately $295 million. Paik Jong-won recently gained international attention through Netflix's hit show, Culinary Class Wars, which topped the global charts for non-English titles.
A rising number of German companies are preparing for initial public offerings (IPOs) despite concerns about the sluggish economy. The Frankfurt Stock Exchange has recorded four IPOs this year, raising a total of $2.2 billion, matching last year's figures but significantly lower than in 2021, according to data from Bloomberg.
Recursion Pharmaceuticals Inc (RXRX) is set to release its Q3 2024 earnings on November 6, with revenue expected at $29.84 million and a loss of $0.37 per share. For the full year, revenue estimates have risen to $69 million, with a projected loss of $1.63 per share. Analysts have set a 12-month average price target of $10.14, indicating a potential upside of 53.22% from the current price of $6.62.
Vertex Pharmaceuticals reported Q3 earnings of $4.38 per share, exceeding estimates and showing a year-over-year increase from $4.08. Revenues reached $2.77 billion, surpassing expectations and up from $2.48 billion a year ago. Despite a 15.8% rise in shares this year, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Dabur is currently trading at 46x/40x on FY26/FY27E P/E, with a 2-3% EPS trim for FY25-27E. Despite a slight miss in Q2FY25 results due to distributor inventory corrections and adverse weather impacting beverage sales, the company anticipates a recovery in revenue growth and stable margins in H2FY25. Analysts maintain a positive outlook, citing favorable risk-reward dynamics following a stock price correction.
The Nasdaq led a significant sell-off in US stocks, dropping 2.7% after earnings reports from Meta and Microsoft raised concerns about rising AI costs impacting profitability. The S&P 500 and Dow also recorded monthly losses, ending a five-month gain streak. Despite initial worries, Amazon's stock rose after it exceeded revenue and earnings expectations, while Apple shares fell slightly due to a one-time charge. Investors are awaiting the upcoming jobs report and the Federal Reserve's policy decision next week.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.